Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
48.5M
Number of holders
66
Total 13F shares, excl. options
31M
Shares change
+6.44M
Total reported value, excl. options
$607M
Value change
+$126M
Number of buys
45
Number of sells
-12
Price
$19.39

Significant Holders of Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA) as of Q4 2024

71 filings reported holding ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q4 2024.
Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 31M shares of 48.5M outstanding shares and own 64.02% of the company stock.
Largest 10 shareholders include FMR LLC (5.51M shares), Fairmount Funds Management LLC (3.37M shares), VR Adviser, LLC (3.29M shares), RTW INVESTMENTS, LP (1.95M shares), VANGUARD GROUP INC (1.61M shares), COMMODORE CAPITAL LP (1.42M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.33M shares), BRAIDWELL LP (1.15M shares), JANUS HENDERSON GROUP PLC (849K shares), and PERCEPTIVE ADVISORS LLC (846K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.